US FDA urges infant-formula makers to tighten supplier oversight after product recalls, botulism outbreaks

July 14, 2026
The Food and Drug Administration has ‌so far ⁠investigated two multi-state ⁠outbreaks of infant botulism associated with two separate brands of powdered infant ​formula – ByHeart and Nara Organics – that resulted in the products being recalled, it said ​in its letter to manufacturers, packagers, distributors, exporters, importers, and retailers of infant formula.